Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

toothbrush

Sanofi reception

Type 1 diabetes market to double to $13.6bn

New treatments will see this growth by 2023, according to GlobalData

- PMLiVE

FDA panel backs GSK’s asthma drug Breo for adults only

Already approved to treat COPD in the US

Zealand announces management changes

Firm making the roles of chief scientific officer and chief operating officer redundant

- PMLiVE

AZ and Daiichi Sankyo sign Movantik marketing deal

Two firms have agreed the deal for the new constipation pill

Eli Lilly HQ

Lilly inks $690m deal with Hanmi for autoimmune drug

Lilly to pay $50m upfront for rights to HM71224

Under pressure

Life science companies must prioritise their response to market changes

- PMLiVE

R&D productivity takes off

Approvals of NMEs reach heights last seen in the mid-1990s

- PMLiVE

GSK: We had a social responsibility to work on Ebola

And company says it delayed more commercialprojects to do so

- PMLiVE

Call for closer ties between pharma and animal health

One Health conference hears how joint workingcould benefit both sectors

- PMLiVE

23andMe expands into the drug discovery business

Firm will use its genetic data for its new research arm

- PMLiVE

UK Budget welcomed by life science industry

New measures include a £20m health funding boost for the north of England

- PMLiVE

US pharma market to reach $550bn by 2020

Health reforms and the new FDA initiatives among the factors that will help it grow

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links